$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week


Prev. Close
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc. engages in the provision of technologies to treat and prevent infectious diseases. Its technology platforms include antibody, T cell, innate immunity, and siRNA. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in 2016 and is headquartered in San Francisco, CA.
Sector
Commercial Services
CEO
George A. Scangos
Industry
Miscellaneous Commercial Services
Exchange
NASDAQ
Website
Top Stories
Coming soon.